Nocebo in multiple sclerosis trials: a meta-analysis on oral and newer injectable disease-modifying treatments

ConclusionsOral DMTs may be associated with a higher incidence and greater nocebo severity than newer injectables.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research